Navigation Links
Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009
Date:9/9/2008

- Advances Achieved in All Clinical Programs, With Three Bavituximab Phase

II Cancer Trials Ongoing - - Updated Initial Data from Bavituximab Plus Docetaxel Phase II Breast Cancer Trial Shows at Least 9 of 14 Evaluable Patients Achieved a Partial

Tumor Response - - Company Begins Work under Contract with Defense Threat Reduction Agency

Potentially Worth Up to $44.4 Million -

TUSTIN, Calif., Sept. 9 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced financial results for the first quarter of fiscal year (FY) 2009 ended July 31, 2008. The company reported a consolidated net loss of $5,086,000, or $0.02 per basic and diluted share, compared to a consolidated net loss of $4,656,000 or $0.02 per basic and diluted share for the same prior year period. The increased net loss primarily reflects increased investments in research and development as the company advanced its clinical programs for bavituximab and Cotara(R).

Total revenues for the current quarter were $1,517,000 compared to $1,625,000 for the comparable quarter last year and were primarily generated from services provided by Avid Bioservices, the company's wholly owned contract manufacturing subsidiary. Total revenues for the quarter also include the first government contract revenues generated by Peregrine's contract with the Defense Threat Reduction Agency (DTRA), potentially worth up to $44.4 million over a period of up to five years to evaluate bavituximab for the prevention or treatment of viral hemorrhagic fever infections.

Total costs and expenses increased to $6,677,000 in the first quarter of FY 2009 from $6,513,000 in the same prior year
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Peregrine Pharmaceuticals to Report First Quarter FY 2009 Financial Results
2. Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule
3. Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008
4. Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
5. Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study
6. Peregrine Pharmaceuticals Reports Studies Published in Science Highlight Key Role of Phosphatidylserine (PS) in Viral Infections
7. Peregrine Pharmaceuticals Announces Four Upcoming Presentations at the American Association for Cancer Research 2008 Annual Meeting
8. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
9. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
10. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
11. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Carolina (PRWEB) September 24, 2014 Spirax ... trap constructed to withstand corrosion from clean and ... ASME standards and is designed to remove condensate from ... ideal for the pharmaceutical, biotechnology, and food and beverage ... to steam saturation temperatures, reducing condensate back up and ...
(Date:9/23/2014)... University of Texas at Austin and Northwestern University ... reliability and performance of transistors and circuits based ... has long been considered by scientists as one ... smaller, faster and cheaper electronic devices. The result ... journal Applied Physics Letters , from AIP ...
(Date:9/23/2014)... the University of Southampton,s Optoelectronics Research Centre (ORC) ... potential challenger to graphene. , Graphene, a single ... is increasingly being used in new electronic and ... sources, thanks to the unprecedented properties it offers: ... mechanically stretchable yet harder than diamond. , Now, ...
(Date:9/23/2014)... ceramics have potential uses as ferroelectrics, fast ion ... waste, generating a great deal of scientific interest ... blended materials. , "The interfaces separating the different ... properties of the material as a whole," said ... on the project. "It is in the chemical ...
Breaking Biology Technology:Spirax Sarco Announces the BTS7.1 Stainless Steel Clean Steam Trap 2Future flexible electronics based on carbon nanotubes 2Future flexible electronics based on carbon nanotubes 3Future flexible electronics based on carbon nanotubes 4Southampton scientists grow a new challenger to graphene 2Los Alamos researchers uncover properties in nanocomposite oxide ceramics for reactor fuel 2
... Calif., Feb. 6 Onyx,Pharmaceuticals, Inc. (Nasdaq: ... the BIO CEO & Investor Conference on Wednesday, ... may access a live webcast of the,presentation at:, ... log on 15 minutes early in order to,register ...
... Avatar Software Platform Further Solidifies Netsmart as Leader in Behavioral ... ... Florida, GREAT RIVER, N.Y., Feb. 6 Netsmart Technologies, ... services organizations, today announced it has signed a contract to,provide comprehensive ...
... Global Probiotics Council,(GPC), a committee established in 2004 ... the Young Investigator Grant for probiotics research,program (YIGPRO) ... stimulate,innovative research and to support young investigators and ... field of probiotics and gut,microbiota., "Our two ...
Cached Biology Technology:Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions 2Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions 3Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research 2Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research 3Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research 4
(Date:9/23/2014)... Ill. Antarctic fishes that manufacture their own ... Ocean also suffer an unfortunate side effect, researchers ... their bodies resist melting even when temperatures warm. ... Proceedings of the National Academy of Sciences ... an undesirable consequence of the evolution of antifreeze ...
(Date:9/23/2014)... has domesticated animals, selecting the best traits possible ... an intriguing animal to examine adaptation to climate ... selected breeding and a wealth of livestock genome-wide ... study that combined molecular and environmental data, professor ... genes under environmental selection from domesticated sheep breeds. ...
(Date:9/23/2014)... successful rise and fall of an athlete,s moving body relies ... putting the many angles and intersecting planes literally the ... to the test. But it,s more than just a footfall ... of sports injuries: the ACL or anterior cruciate ligament tear. ... at the center of the knee joint and volume ...
Breaking Biology News(10 mins):Study: Antifreeze proteins in Antarctic fishes prevent freezing ... and melting 2Study: Antifreeze proteins in Antarctic fishes prevent freezing ... and melting 3Being sheepish about climate adaptation 2Does size matter? MRI imaging sheds light on athletes most at risk for severe knee injury 2Does size matter? MRI imaging sheds light on athletes most at risk for severe knee injury 3
... in 100 inhabitants died from Spanish flu in 1918, but ... An important explanation for the differences is due to different ... came. Those living in urban communities probably had a higher ... in 1918 than those living in very isolated rural areas. ...
... other businesses step up efforts to cut waste, reduce ... products and processes, the number of planet-friendly standards and ... a sometimes-confusing array of options for "going green." National ... a framework to help organizations of all types sort ...
... Article highlights from the May issue of The American Naturalist ... a second, Genes control fruit flies, social groupings, What can twins ... issue table of contents, go to www.journals.uchicago.edu/an . ... kstacey@press.uchicago.edu . Cuttlefish: From camo to tuxedo ...
Cached Biology News:Large differences in mortality between urban and isolated rural areas 2Large differences in mortality between urban and isolated rural areas 3NIST prototypes framework for evaluating sustainability standards 2Tipsheet for the May issue of the American Naturalist 2Tipsheet for the May issue of the American Naturalist 3
Umbilical cord blood CD4+ T cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
Human peripheral blood CD14+ monocytes, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Human endothelial progenitor cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
Yeast tRNA 50 l...
Biology Products: